跳至主要内容
临床试验/CTRI/2022/08/044601
CTRI/2022/08/044601尚未招募未知

Role of procalcitonin in guiding antimicrobial usage in acute pancreatitis ââ?¬â?? a randomized clinical trial

JIPMER0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
JIPMER

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients over the age of 18 years of age
  • 2. A diagnosis of acute pancreatitis requiring two of the following three features [7]:
  • I. abdominal pain consistent with acute pancreatitis (acute onset of a persistent, severe, epigastric pain often radiating to the back)
  • II. serum lipase activity (or amylase activity) at least three times greater than the upper limit of normal
  • III. Characteristic findings of acute pancreatitis on contrast-enhanced computed tomography (CECT), magnetic resonance imaging (MR) or transabdominal ultrasonography

排除标准

  • 1. Comorbidities requiring prolonged antibiotic therapyââ?¬â?such as infective endocarditis
  • 2. Severely immunocompromised patientsââ?¬â?such as those with human immunodeficiency virus and with a CD4 count of less than 200 cells/mm3 ; neutropenic patients ( < 500 neutrophils/mm3 )
  • 3. Patients on immunosuppressive therapy
  • 4. Previous thyroid surgery

研究者

发起方
JIPMER

相似试验